Skip to main content

Table 4 Nadir PSA subgroups and their corresponding 5 and 10-years biochemical free survival

From: Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivation

Subcategories

5-years BFS rate (%)

10-years BFS rate (%)

nPSA < 0.06

95.7

79.6

0.06 < nPSA < 0.5

76.6

58.8

nPSA > 0.5

56

0

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us